ASMANEX TWISTHALER 200 MCG
MOMETASONE FUROATE : 200 MCG · DIN 02243595 · ORGANON CANADA INC.
Health Canada status: MARKETED
What is ASMANEX TWISTHALER?
ASMANEX TWISTHALER 200 MCG contains MOMETASONE FUROATE : 200 MCG. It is listed in the Health Canada Drug Product Database under DIN 02243595, held by ORGANON CANADA INC., supplied as POWDER for INHALATION administration. Health Canada currently lists it as marketed, status dated 12-Aug-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ASMANEX TWISTHALER used for?
Prophylactic management of steroid-responsive bronchial asthma in patients 4 years of age and older. Not for acute treatment.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02243595 |
|---|---|
| Brand name | ASMANEX TWISTHALER |
| Generic / active ingredient | MOMETASONE FUROATE : 200 MCG |
| Manufacturer | ORGANON CANADA INC. |
| Strength | 200 MCG |
| Dosage form | POWDER |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03BA07 MOMETASONE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Aug-2022 |
| Original market date | 2011-12-21 00:00:00 |
How is it administered?
Oral inhalation only. Adults/Adolescents (12+): 200-400 mcg once daily (evening) or 200-400 mcg twice daily. Pediatrics (4-11): 100 mcg once daily (evening). Rinse mouth after use.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text snippet (standard section 11 is listed in TOC but text ends at section 7). Typically 15-30°C.
How is it supplied?
Multi-dose dry powder inhaler with 7, 14, 30, or 60 metered doses. Supplied in a protective foil pouch. Inhalers have color-coded grips (grey, pink, or maroon).
Contraindications
Hypersensitivity to mometasone furoate, milk proteins (lactose), or any ingredient. Primary treatment of status asthmaticus. Untreated systemic infections (fungal, bacterial, viral, parasitic).
Warnings and precautions
Not for acute attacks. Risk of HPA-axis suppression, adrenal insufficiency when transferring from oral steroids, immunosuppression (chickenpox/measles risk), and reduced bone mineral density.
What can be used instead?
Other Canadian products sharing ATC code R03BA07 MOMETASONE. 3 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ASMANEX TWISTHALER | 100 MCG | POWDER | ORGANON CANADA INC. | MARKETED | DIN 02438690 |
| ASMANEX TWISTHALER | 400 MCG | POWDER | ORGANON CANADA INC. | MARKETED | DIN 02243596 |
Who else supplies MOMETASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MOMETASONE appears in 2383 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.